scholarly article | Q13442814 |
P819 | ADS bibcode | 2008PNAS..10518907D |
P356 | DOI | 10.1073/PNAS.0810111105 |
P932 | PMC publication ID | 2585942 |
P698 | PubMed publication ID | 19028876 |
P5875 | ResearchGate publication ID | 23492775 |
P2093 | author name string | Jessica L Goodman | |
L Charles Murtaugh | |||
Lyska L Emerson | |||
Jean-Paul De La O | |||
Andrew B Curtis | |||
Benjamin E Illum | |||
Scott C Froebe | |||
P2860 | cites work | Notch signaling controls multiple steps of pancreatic differentiation | Q24569636 |
Beta-catenin is essential for pancreatic acinar but not islet development | Q28512693 | ||
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors | Q29619012 | ||
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
Pancreatic cancer. | Q30490247 | ||
A PCR primer bank for quantitative gene expression analysis | Q33447710 | ||
Gene regulatory factors in pancreatic development | Q34286940 | ||
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma | Q34642090 | ||
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia | Q35663506 | ||
Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia | Q35928158 | ||
The love-hate relationship between Ras and Notch. | Q36231474 | ||
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. | Q36362278 | ||
In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia | Q36478584 | ||
Notch signaling is required for exocrine regeneration after acute pancreatitis. | Q40017803 | ||
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras | Q40424687 | ||
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context | Q40637553 | ||
Increased expression of hypoxia-inducible factor-1alpha, p48, and the Notch signaling cascade during acute pancreatitis in mice | Q44715476 | ||
Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration | Q46376132 | ||
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas | Q46708964 | ||
Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice | Q53379866 | ||
The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice | Q53379869 | ||
Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult Mice | Q61776577 | ||
Isolation of RNA using guanidinium salts | Q69005967 | ||
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis | Q73614651 | ||
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells | Q74624551 | ||
Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates | Q80378426 | ||
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma | Q82193149 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | intraepithelial neoplasia | Q6058399 |
P304 | page(s) | 18907-18912 | |
P577 | publication date | 2008-11-21 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia | |
P478 | volume | 105 |
Q28082890 | A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas |
Q38852413 | A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancer |
Q91711463 | ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis |
Q38922230 | Acinar cell plasticity and development of pancreatic ductal adenocarcinoma |
Q38459854 | Acinar cell reprogramming: a clinically important target in pancreatic disease |
Q42282476 | Acinar cells in the neonatal pancreas grow by self-duplication and not by neogenesis from duct cells |
Q82181907 | Acinar‐to‐ductal metaplasia accompanies c‐myc‐induced exocrine pancreatic cancer progression in transgenic rodents |
Q38461863 | Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. |
Q54526478 | Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1 |
Q27312357 | Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage |
Q34082522 | Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras |
Q34046479 | Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style |
Q90240762 | Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer |
Q37628092 | Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas |
Q89285906 | Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM |
Q35176052 | Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype |
Q33832727 | Basal but not luminal mammary epithelial cells require PI3K/mTOR signaling for Ras-driven overgrowth. |
Q33604913 | Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice |
Q37182612 | Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis |
Q35228755 | Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation |
Q36823886 | Cell Fate Decisions During Breast Cancer Development |
Q33767473 | Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity |
Q29619557 | Cells of origin in cancer |
Q39161835 | Cells of origin of pancreatic neoplasms |
Q39379039 | Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1. |
Q36096239 | Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer |
Q37709553 | Cellular plasticity within the pancreas--lessons learned from development |
Q37411831 | Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis |
Q91526219 | Characterization of genetic subclonal evolution in pancreatic cancer mouse models |
Q36929317 | Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1 |
Q39051424 | Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression |
Q34620985 | Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras |
Q27021239 | Control of Cell Identity in Pancreas Development and Regeneration |
Q35578568 | Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice |
Q34201623 | Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models |
Q41906889 | DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer |
Q42826326 | DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. |
Q40003054 | Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis |
Q35622126 | Deploying mouse models of pancreatic cancer for chemoprevention studies |
Q26774942 | Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin |
Q35432049 | Dicer is required for maintenance of adult pancreatic acinar cell identity and plays a role in Kras-driven pancreatic neoplasia |
Q35161464 | Dicer regulates differentiation and viability during mouse pancreatic cancer initiation |
Q39278421 | Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer |
Q39384816 | Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis |
Q36673216 | Direct reprogramming by oncogenic Ras and Myc. |
Q41845030 | Disputed Paternity: The Uncertain Ancestry of Pancreatic Ductal Neoplasia |
Q90139280 | Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma |
Q55616605 | E47 Governs the MYC-CDKN1B/p27KIP1-RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16INK4A and Wild-Type p53. |
Q89151859 | EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration |
Q47281933 | EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis |
Q38314944 | EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis |
Q38673285 | EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma |
Q33818230 | Epithelial Tissues Have Varying Degrees of Susceptibility to KrasG12D-Initiated Tumorigenesis in a Mouse Model |
Q34456195 | Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX. |
Q47121552 | Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice. |
Q38022404 | Exocrine ontogenies: on the development of pancreatic acinar, ductal and centroacinar cells |
Q28482954 | Exocrine pancreatic carcinogenesis and autotaxin expression |
Q30422901 | Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. |
Q27004534 | From fly wings to targeted cancer therapies: a centennial for notch signaling |
Q37821995 | GI GEMs: Genetically Engineered Mouse Models of Gastrointestinal Disease |
Q30620697 | Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation |
Q34454159 | Gene delivery to pancreatic exocrine cells in vivo and in vitro. |
Q88688533 | Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets |
Q27002973 | Genetically engineered mouse models of pancreatic adenocarcinoma |
Q36675786 | Genetically engineered mouse models of pancreatic cancer |
Q42738166 | Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations |
Q39556322 | Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma |
Q37103319 | High NOTCH activity induces radiation resistance in non small cell lung cancer |
Q27023576 | Human Correlates of Provocative Questions in Pancreatic Pathology |
Q52603542 | Id3 modulates cellular localization of bHLH Ptf1‐p48 protein |
Q41856856 | Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma |
Q33921337 | Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis |
Q41854156 | Impact of Sox9 dosage and Hes1-mediated Notch signaling in controlling the plasticity of adult pancreatic duct cells in mice. |
Q40730244 | Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma. |
Q55252335 | In vivo reprogramming drives Kras-induced cancer development. |
Q37068621 | Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma |
Q33486497 | Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas |
Q39885220 | Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma |
Q50087583 | Injury, repair, inflammation and metaplasia in the stomach. |
Q37334274 | Interaction of stellate cells with pancreatic carcinoma cells |
Q36068611 | K-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions |
Q35083740 | KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations |
Q33858490 | KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. |
Q100428129 | Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer |
Q30396675 | Leptin-Notch signaling axis is involved in pancreatic cancer progression |
Q50517982 | Lineage Tracing Evidence for Transdifferentiation of Acinar to Duct Cells and Plasticity of Human Pancreas |
Q41602913 | Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. |
Q53176733 | Liver and pancreas: do similar embryonic development and tissue organization lead to similar mechanisms of tumorigenesis? |
Q33754775 | Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia |
Q53215067 | Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer |
Q47246517 | Luteolin inhibits pancreatitis‑induced acinar‑ductal metaplasia, proliferation and epithelial‑mesenchymal transition of acinar cells. |
Q35388201 | MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling |
Q38680703 | Macrophages and pancreatic ductal adenocarcinoma |
Q39337159 | Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. |
Q37998643 | Malignant glioma: lessons from genomics, mouse models, and stem cells |
Q37421292 | Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis |
Q50964950 | Mechanistic insights into the activity of Ptf1-p48 (pancreas transcription factor 1a): probing the interactions levels of Ptf1-p48 with E2A-E47 (transcription factor E2-alpha) and ID3 (inhibitor of DNA binding 3). |
Q39250469 | Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells |
Q27334957 | Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer |
Q91871177 | Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture |
Q39441268 | Molecular Events in the Natural History of Pancreatic Cancer |
Q37538446 | Molecular and cellular regulation of pancreatic acinar cell function |
Q37809242 | Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways |
Q26999345 | Molecular mechanism underlying lymphatic metastasis in pancreatic cancer |
Q37176648 | Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy |
Q26860574 | Mouse models of pancreatic cancer |
Q38974147 | NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. |
Q26771258 | Notch Signaling in Pancreatic Development |
Q41858645 | Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling |
Q39116742 | Notch as a tumour suppressor. |
Q38094850 | Notch signaling in pancreatic cancer: oncogene or tumor suppressor? |
Q37785204 | Notch signaling in solid tumors. |
Q36881446 | Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. |
Q34982347 | Notch signaling proteins: legitimate targets for cancer therapy |
Q37867484 | Notch signalling in solid tumours: a little bit of everything but not all the time |
Q39169243 | Notch1 Contributes to Chemoresistance to Gemcitabine and Serves as an Unfavorable Prognostic Indicator in Pancreatic Cancer |
Q34533078 | Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma |
Q40865845 | Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma |
Q34068002 | Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma |
Q39156056 | Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation |
Q42937848 | Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia |
Q38329689 | Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. |
Q34456438 | Organoid models of human and mouse ductal pancreatic cancer |
Q87195787 | Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene |
Q51228273 | Overview of the pancreatic toxicity and carcinogenesis session |
Q34101017 | PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia |
Q37587988 | PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance |
Q34616196 | PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice |
Q34134396 | PTEN loss accelerates KrasG12D-induced pancreatic cancer development |
Q92078077 | PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-CateninY654 |
Q92959992 | Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis |
Q42556570 | Pancreatic cancer: translational research aspects and clinical implications. |
Q39356850 | Pancreatic differentiation of human dental pulp CD117⁺ stem cells |
Q37249748 | Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia |
Q27006729 | Pancreatic ductal cells in development, regeneration, and neoplasia |
Q37243095 | Pancreatic regenerating gene I and acinar cell differentiation: influence on cellular lineage |
Q42573716 | Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence |
Q37589374 | Pathogenesis of pancreatic cancer: lessons from animal models |
Q26764921 | Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer |
Q54273913 | Phosphorylation of Ribosomal Protein S6 Attenuates DNA Damage and Tumor Suppression during Development of Pancreatic Cancer |
Q41737306 | Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease |
Q90425919 | Plasticity of differentiated cells in wound repair and tumorigenesis, part I: stomach and pancreas |
Q28480889 | Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia |
Q36700012 | Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation |
Q45415868 | Putting GWAS to the functional test: NR5A2 and pancreatic cancer risk |
Q36367896 | Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma |
Q39841946 | Ras activity levels control the development of pancreatic diseases. |
Q38014542 | Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research |
Q35071666 | Regeneration and repair of the exocrine pancreas |
Q28086849 | Regulation of Cellular Identity in Cancer |
Q26801731 | Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract |
Q28478427 | Retracted: Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-κB Signaling Pathways |
Q37501557 | Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia |
Q37621990 | SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms |
Q57829104 | SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression |
Q57471060 | SWI/SNF component restrains pancreatic neoplasia formation |
Q37726658 | Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. |
Q36210472 | Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis |
Q27334054 | Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis |
Q42668097 | Sin3B expression is required for cellular senescence and is up-regulated upon oncogenic stress |
Q50420111 | Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone. |
Q38103364 | Sox9 and programming of liver and pancreatic progenitors |
Q33976991 | Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma |
Q34972366 | Sox9: a master regulator of the pancreatic program |
Q34786695 | Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. |
Q38170621 | Stem cell-directed therapies in pancreatic cancer |
Q46092740 | Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas |
Q37273793 | Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia |
Q37147887 | TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells |
Q41463557 | Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer. |
Q37730861 | Targeting Notch signaling in pancreatic cancer |
Q52333009 | Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. |
Q56967209 | The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis |
Q65002383 | The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice. |
Q35083157 | The MEK/ERK pathway promotes NOTCH signalling in pancreatic cancer cells |
Q38122526 | The Plastic Pancreas |
Q57094352 | The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer |
Q35954277 | The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma |
Q38919135 | The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice |
Q38220439 | The architect who never sleeps: tumor-induced plasticity |
Q35732360 | The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential. |
Q38972919 | The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma |
Q38161372 | The many faces of wnt and pancreatic ductal adenocarcinoma oncogenesis |
Q37808123 | The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement |
Q33827679 | The secret origins and surprising fates of pancreas tumors |
Q36357873 | Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans |
Q36088793 | Transdifferentiation of tadpole pancreatic acinar cells to duct cells mediated by Notch and stromelysin-3 |
Q42736382 | Tumor initiating cells in pancreatic cancer: A critical view. |
Q28083091 | Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models |
Q64067178 | Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs |
Q34160508 | Zebrafish Models for Cancer |
Q64321325 | Zebrafish model of -initiated pancreatic cancer |
Q30581795 | Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer |
Q53021022 | p21(WAF1) (/Cip1) limits senescence and acinar-to-ductal metaplasia formation during pancreatitis |
Q36051065 | β-catenin is selectively required for the expansion and regeneration of mature pancreatic acinar cells in mice |
Search more.